Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Tixocortol is a corticosteroid used for the symptomatic treatment of rhinitis, pharyngitis, and ulcerative colitis. Tixocortol is a 21-thiol derivative of hydrocortisone classified as a class A corticosteroid.
- Mechanism
- Curator reviewed · 1 reference
The mechanism of action of tixocortol is similar to other corticosteroids regarding the binding sites and prostaglandin synthesis but the local properties of tixocortol are given by the immediate liver metabolism and transformation withing red blood cells. All the immediate transformations of tixocortol classified it as part of the nonsystemic steroids.
- Primary indication
- Tixocortol is indicated for the treatment of rhinitis as a nasal suspension or aerosol.Curator reviewed
- Formula / weight
- C21H30O4S · 378.53 g/mol (avg)
- First approval
- Canada, 1997 · United States, 2012
Resolves to
YWDBSCORAARPPF-VWUMJDOOSA-NSMILES[H][C@@]12CC[C@](O)(C(=O)CS)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12CWhat you can answer from here — as of September 13, 2026
Which drugs share a target with Tixocortol, and which of those have an active Phase 3 trial?